MAIA · MAIA Biotechnology, Inc. · Executive Compensation

$1.01 -0.02 (-1.94%) At close · Nov 12

Market Cap

$62.37M

61.75M

Volume · Nov 12 273.94K Avg daily vol (3M) 447.24K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vlad Vitoc	M.D. M.B.A. Chief Executive Officer and President	$612,333	$334,813	—	$1,124,480	—	$13,006	$2,084,632
Sergei M. Gryaznov	Chief Scientific Officer	$478,500	$213,813	—	$562,240	—	$12,741	$1,267,294
Jeffrey C. Himmelreich	Head of Finance	$272,917	$68,229	—	$69,602	—	$10,240	$420,988

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vlad Vitoc	M.D. M.B.A. Chief Executive Officer and President	$473,000	$236,500	—	$637,480	—	$13,461	$1,360,441
Sergei M. Gryaznov	Chief Scientific Officer	$363,000	$145,200	—	$408,177	—	$13,461	$929,838
Jeffrey C. Himmelreich	Head of Finance	$240,000	—	—	$31,874	—	$9,125	$338,374

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vlad Vitoc	M.D. M.B.A. Chief Executive Officer and President	$473,000	—	—	$900,934	—	$12,306	$1,386,240
Sergei M. Gryaznov	Chief Scientific Officer	$363,000	—	—	$477,415	—	$12,306	$852,721

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vlad Vitoc	M.D. M.B.A. Chief Executive Officer and President	$442,542	$236,500	—	$492,220	—	$36,508	$1,207,770
Mihail Obrocea	Chief Medical Officer	$391,083	$167,200	—	$246,110	—	$47,101	$851,494
Sergei M. Gryaznov	Chief Scientific Officer	$339,625	$145,200	—	$246,110	—	$39,944	$770,879
Joseph F. McGuire	Chief Financial Officer	$308,750	$132,000	—	$246,110	—	$47,128	$733,988

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mihail Obrocea	Chief Medical Officer	$162,500	$57,731	—	$1,907,411	—	$18,344	$2,145,986
Joseph F. McGuire	Chief Financial Officer	$112,500	$39,519	—	$700,258	—	$26,035	$878,312
Sergei M. Gryaznov	Chief Scientific Officer	$238,542	$115,500	—	$183,980	—	$38,485	$576,507

Executive changes

Person	Role	Change	Effective	Filed
Jeffrey Himmelreich	Head of Finance and principal financial and accounting officer	Appointed	2023-11-10	2023-11-15
Dr. Mihail Obrocea	Chief Medical Officer	Terminated	2023-11-10	2023-11-15
Joseph McGuire	Chief Financial Officer (and principal financial and accounting officer)	Terminated	2023-11-10	2023-11-15
Stan Smith	member of the Audit Committee	Appointed	2023-03-16	2023-03-17
Jean-Manassé Theagène	Class III director	Appointed	2023-03-17	2023-03-17
Laurentiu Vlad	Director	Resigned	2023-03-16	2023-03-17
Joseph McGuire	Chief Financial Officer	Appointed	2022-09-16	2022-09-21

Leadership

Vlad Vitoc CEO
Jeffrey Himmelreich CFO
Joseph McGuire CFO
Cristian Luput Board Member
Jean-Manassé Theagène Board Member
Louie Ngar Yee Board Member
Ramiro Guerrero Board Member
Stan Smith Board Member
Stan V. Smith Board Member
Steven Chaouki Board Member

Key facts CIK 1878313 CUSIP 552641102 13F (30d) 17 filings 17 filers Visit website Investor relations